Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Thymus Neoplasms 1 Neuroblastoma 1 Mesothelioma 1 Lung Neoplasms 1 Hernia, Hiatal 1 Gastroesophageal Reflux 1 Esophageal Neoplasms 1 Esophageal Diseases 1 Esophageal Achalasia 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Cancer Female 1 Adenocarcinoma 1

Interventions

Oxaliplatin 13 Bevacizumab 11 Capecitabine 10 Fluorouracil 8 Blood Specimen Collection 8 Leucovorin 7 Cetuximab 6 pembrolizumab 5 Folfox protocol 5 trifluridine tipiracil drug combination 4 dostarlimab 4 Nivolumab 4 Irinotecan 4 HMPL-013 4 Drug Therapy 4 fludarabine 3 XELOX 3 Specimen Handling 3 Laparoscopy 3 IFL protocol 3 Cyclophosphamide 3 Biopsy 3 tislelizumab 2 tipiracil 2 regorafenib 2 pertuzumab 2 envafolimab 2 encorafenib 2 cemiplimab 2 atezolizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Colonic Neoplasms × Tumor Burden × Clear all

NCT05955196 2024-10-09

MACROSWITCH

Institut Paoli-Calmettes

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡